Skip to content
HeyJared

Biocentury Staff

Reporter

Indexed articles, last 90 days
50
Latest publication
Jul 31, 2026
Outlet visibility, for BioCentury
Top 5M sites
Earliest in this view
Jul 15, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Jul 31, 2026 · BioCentury Staff

    Replimune bounces back on FDA panel vote (opens the original)

    Excerpt

    Read excerpt

    BIOCENTURY | DATA BYTEREPLIMUNE BOUNCES BACK ON FDA PANEL VOTEAdvisory committee supports RP1 despite negative briefing docs

  2. Article · Jul 31, 2026 · BioCentury Staff

    Spot Bio: Delivering full-length genes to muscle without viruses (opens the original)

    Excerpt

    Read excerpt

    BIOCENTURY | EMERGING COMPANY PROFILESPOT BIO: DELIVERING FULL-LENGTH GENES TO MUSCLE WITHOUT VIRUSESExtracellular vesicle-delivered DMD gene therapy enters investigator-led testing, with ischemic injury next

  3. Article · Jul 31, 2026 · BioCentury Staff

    Apnimed gains in aftermarket as three biotechs outline IPO aims: Finance Report (opens the original)

    Excerpt · Neutral tone

    Read excerpt

    BIOCENTURY | FINANCEAPNIMED GAINS IN AFTERMARKET AS THREE BIOTECHS OUTLINE IPO AIMS: FINANCE REPORTBraveheart, Attovia, Vogenx could be next to reach NASDAQ; plus, Yarrow’s PIPE, Claris’ nine-figure venture round; and more

  4. Article · Jul 31, 2026 · BioCentury Staff

    AI biotechs punched above their weight in 1H26 venture megarounds (opens the original)

    Excerpt

    Read excerpt

    BIOCENTURY | DATA BYTEAI BIOTECHS PUNCHED ABOVE THEIR WEIGHT IN 1H26 VENTURE MEGAROUNDSAI biotech financings were three times as likely to top $200M, even as the category’s median round trailed non-AI biotechs

  5. Article · Jul 31, 2026 · BioCentury Staff

    Antisense pioneer Bennett to retire (opens the original)

    Excerpt

    Read excerpt

    BIOCENTURY | MANAGEMENT TRACKSANTISENSE PIONEER BENNETT TO RETIREPlus: J&J vet Rooney joins Kymera, Weiner-Trapness now executive chair of Allergy, Recursion co-founder Gibson becomes partner at Dimension

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 5M sites

For BioCentury, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Biocentury Staff